ZFIN Image: Nguyen et al., 2012, Fig. 1

Image

Figure Caption

Fig. 1

Mifepristone-inducible liver-specific kras^V12 expression in transgenic zebrafish. (A) Schematic diagram of the mifepristone-inducible LexPR system with separate liver-driver and Ras-effector constructs. The liver-specific expression of EGFP-kras^V12 in double-transgenic fish (driver-effector), harboring both cassettes, is activated in trans by the LexPR activator produced from the liver-driver in the presence of mifepristone (RU486). (B–E) Representative 7-dpf fry from the liver-driver (B), Ras-effector (C) and driver-effector double transgenics (D,E). All fry were incubated with 1 µM mifepristone from 3 dpf. The upper panels show a fluorescent image and the lower panels show histology. The liver-driver fry had induced EGFP expression in the liver and a normal liver histology (B). The Ras-effector fry had mCherry expression in the lens as a transgenic marker but no induced EGFP expression in the liver, and also had a normal liver histology (C). EGFP-kras^V12 expression was induced in driver-effector double-transgenic larvae at 3 dpf, causing the development of an enlarged and hyperplastic liver (D) and some individuals showed invasive EGFP-positive cells as indicated by arrows (E). Dotted areas indicate the liver regions. Scale bars: 50 μm.

Figure Data

Expression / Labeling details

Phenotype details

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dis. Model. Mech.